These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China. Qiu AD, Wu EQ, Yu XH, Jiang CL, Jin YH, Wu YG, Chen Y, Chen Y, Shan YM, Zhang GN, Fan Y, Zha X, Kong W. Gynecol Oncol; 2007 Jan; 104(1):77-85. PubMed ID: 16970982 [Abstract] [Full Text] [Related]
6. Intratypic variants of human papillomavirus type 16 and risk of cervical neoplasia in Taiwan. Chang YJ, Chen HC, Pan MH, Lee BH, You SL, Lin CY, Chou YC, Hsieh CY, Cheng YJ, Liaw KL, Hsing AW, Schiffman M, Chen CJ, CBCSP-HPV Study Group. J Med Virol; 2013 Sep; 85(9):1567-76. PubMed ID: 23852681 [Abstract] [Full Text] [Related]
8. [Analysis on the expression of human papillomavirus type 16 E2 and E6 oncogenes and disruption of E2 in cervical cancer]. Wang JT, Ding L, Gao ES, Cheng YY. Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):968-71. PubMed ID: 18399141 [Abstract] [Full Text] [Related]
9. [The analysis of human papillomavirus type 16 E6/E7 genetic variability in Yunnan Province, China]. Yang LJ, Yue YF, Chen JY, Pan Y, Zhao YJ, Ma SH, Sun QM. Bing Du Xue Bao; 2012 Nov; 28(6):645-51. PubMed ID: 23367564 [Abstract] [Full Text] [Related]
14. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells. Ding W, Hu Z, Zhu D, Jiang X, Yu L, Wang X, Zhang C, Wang L, Ji T, Li K, He D, Xia X, Liu D, Zhou J, Ma D, Wang H. Clin Cancer Res; 2014 Dec 15; 20(24):6495-503. PubMed ID: 25336692 [Abstract] [Full Text] [Related]
15. Distinctive distribution of HPV16 E6 D25E and E7 N29S intratypic Asian variants in Korean commercial sex workers. Choi BS, Kim SS, Yun H, Jang DH, Lee JS. J Med Virol; 2007 Apr 15; 79(4):426-30. PubMed ID: 17311337 [Abstract] [Full Text] [Related]